96 related articles for article (PubMed ID: 22834671)
1. What is a rational antidepressant treatment for major depression in patients with Parkinson's disease?
Hagikura M; Iwamoto K; Aleksic B; Ozaki N
Psychiatry Clin Neurosci; 2012 Aug; 66(5):463. PubMed ID: 22834671
[No Abstract] [Full Text] [Related]
2. Comments on 'what is a rational antidepressant treatment for major depression in patients with Parkinson's disease?'.
Pae CU
Psychiatry Clin Neurosci; 2013 Jan; 67(1):65-6. PubMed ID: 23331292
[No Abstract] [Full Text] [Related]
3. Treatment with mirtazapine and venlafaxine increases noradrenaline excretion in depressed patients.
Lecei O; Lederbogen F; Gronau W; Scharnholz B; Terhardt J; Schilling C; Gilles M; Kopf D; Roth HJ; Weber-Hamann B; Deuschle M
J Clin Psychopharmacol; 2012 Aug; 32(4):574-6. PubMed ID: 22760352
[No Abstract] [Full Text] [Related]
4. Flunarizine- and topiramate-associated depression responsive to mirtazapine.
Bourgeois JA; Hategan A
Psychosomatics; 2013; 54(5):503-4. PubMed ID: 24034532
[No Abstract] [Full Text] [Related]
5. Re-administration of mirtazapine could overcome previous mirtazapine- associated restless legs syndrome?
Pae CU; Kim TS; Kim JJ; Chae JH; Lee CU; Lee SJ; Paik IH; Lee C
Psychiatry Clin Neurosci; 2004 Dec; 58(6):669-70. PubMed ID: 15601394
[No Abstract] [Full Text] [Related]
6. Use of mirtazapine in an adult with refractory anorexia nervosa and comorbid depression: a case report.
Safer DL; Darcy AM; Lock J
Int J Eat Disord; 2011 Mar; 44(2):178-81. PubMed ID: 20127940
[TBL] [Abstract][Full Text] [Related]
7. Acute reversible dyskinesia induced by mirtazapine.
Konitsiotis S; Pappa S; Mantas C; Mavreas V
Mov Disord; 2005 Jun; 20(6):771. PubMed ID: 15732128
[No Abstract] [Full Text] [Related]
8. Mirtazapine-induced manic switch in adolescent unipolar depression.
Goyal N; Sinha VK
Aust N Z J Psychiatry; 2008 Dec; 42(12):1070-1. PubMed ID: 19031640
[No Abstract] [Full Text] [Related]
9. Disability and borderline personality symptoms.
Sansone RA; Hruschka J; Vasudevan A; Miller SN
Psychosomatics; 2003; 44(5):442. PubMed ID: 12954928
[No Abstract] [Full Text] [Related]
10. Venlafaxine, but not mirtazapine lowers retinol-binding protein 4 serum concentrations in nondiabetic depressed patients.
Deuschle M; Angermeier T; Westphal S; Lederbogen F; Gilles M; Frankhauser P; Schilling C; Onken V; Weber-Hamann B; Kopf D
Psychother Psychosom; 2010; 79(2):123-5. PubMed ID: 20090399
[No Abstract] [Full Text] [Related]
11. Functional dyspepsia and mirtazapine.
Lee SY; Rho SH; Choi SC
Can J Psychiatry; 2002 Aug; 47(6):582-3. PubMed ID: 12211889
[No Abstract] [Full Text] [Related]
12. Mirtazapine for treatment-resistant depression: a preliminary report.
Wan DD; Kundhur D; Solomons K; Yatham LN; Lam RW
J Psychiatry Neurosci; 2003 Jan; 28(1):55-9. PubMed ID: 12587851
[TBL] [Abstract][Full Text] [Related]
13. Mirtazapine-associated dose-dependent and asymptomatic elevation of hepatic enzymes.
Adetunji B; Basil B; Mathews M; Osinowo T
Ann Pharmacother; 2007 Feb; 41(2):359. PubMed ID: 17244643
[No Abstract] [Full Text] [Related]
14. Hyperglycaemia secondary to mirtazapine therapy in a 37-year-old man.
Chen R; Lopes J
Aust N Z J Psychiatry; 2008 Nov; 42(11):990-1. PubMed ID: 18946939
[No Abstract] [Full Text] [Related]
15. [The comparative studies of therapeutic results in patients with psychotic refractory depression treated with selected antidepressants and unilateral ECT].
Hese RT; Gruszczyński W; Szwed A; Kielc M; Zalitacz M
Psychiatr Pol; 2002; 36(6 Suppl):81-4. PubMed ID: 12647425
[TBL] [Abstract][Full Text] [Related]
16. Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.
Fang Y; Yuan C; Xu Y; Chen J; Wu Z; Cao L; Yi Z; Hong W; Wang Y; Jiang K; Gao K; Cui X; Nierenberg AA;
J Clin Psychopharmacol; 2010 Aug; 30(4):357-64. PubMed ID: 20571433
[TBL] [Abstract][Full Text] [Related]
17. Comments on "Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder".
Pae CU
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):597-8. PubMed ID: 17919799
[No Abstract] [Full Text] [Related]
18. Mirtazapine and hyperpigmentation.
Mendhekar D; Inamdar A
World J Biol Psychiatry; 2009; 10(4 Pt 2):688-9. PubMed ID: 19404867
[No Abstract] [Full Text] [Related]
19. Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder.
Kang RH; Wong ML; Choi MJ; Paik JW; Lee MS
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1317-21. PubMed ID: 17618721
[TBL] [Abstract][Full Text] [Related]
20. The effects of mirtazapine on sleep in patients with major depressive disorder.
Dolder CR; Nelson MH; Iler CA
Ann Clin Psychiatry; 2012 Aug; 24(3):215-24. PubMed ID: 22860241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
